Abiopharma

Director Glastra Matthijs 🔴 sold 323 shares of NOVANTA INC (NOVT) at $130.14 Transaction Date: Jan 08, 2026 | Filing ID: 000023

Director Hudson Frederick M. 🟡 adjusted position in 0 shares (1 derivative) of SUPERNUS PHARMACEUTICALS, INC. (SUPN) at $12.98 Transaction Date: Jan 09, 2026 | Filing ID: 001817

📋 MARK R MUNCH (Officer) plans to sell 7K shares of Bruker Corporation (at $55.00 each, total $385K) Filed: Jan 12, 2026 | ID: 000324

New Form SCHEDULE 13G - Galecto, Inc. Filed: 2026-01-12 AccNo: 0001193125-26-010366 Size: 8 KB

📋 Rogers Erica J. (Ex-Director) plans to sell 10K shares of Sight Sciences, Inc. (at $7.38 each, total $74K) Filed: Jan 12, 2026 | ID: 000260

New Form S-8 - Anixa Biosciences Inc Filed: 2026-01-12 AccNo: 0001493152-26-001847 Size: 630 KB

New Form 8-K/A - JOINT Corp Filed: 2026-01-12 AccNo: 0001612630-26-000008 Size: 144 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 3 - Indaptus Therapeutics, Inc. Filed: 2026-01-12 AccNo: 0001493152-26-001846 Size: 3 KB

Rondoni John 🔴 sold 109 shares of Inspire Medical Systems, Inc. (INSP) at $100.00 Transaction Date: Jan 09, 2026 | Filing ID: 002864

HASTINGS DAVID C 🟢 acquired 375.0K shares (1 derivative) of Trevi Therapeutics, Inc. (TRVI) at $11.21 ($4.2M) Transaction Date: Jan 08, 2026 | Filing ID: 010361